Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Celcuity Inc.

CELCNASDAQ
Healthcare
Biotechnology
$106.78
$0.00(0.00%)
U.S. Market is Open • 15:50

Celcuity Inc. (CELC) Stock Overview

Explore Celcuity Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.8B
P/E Ratio-28.72
EPS (TTM)$-3.63
ROE-1.79%
Fundamental Analysis

AI Price Forecasts

1 Month$101.82
3 Months$70.95
1 Year Target$53.46

CELC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Celcuity Inc. (CELC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.36, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $53.46.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -28.72 and a market capitalization of 4.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.86%
5-Day Change
-0.25%
1-Month Change
-0.57%
3-Month Change
11.48%
6-Month Change
114.87%
Year-to-Date (YTD) Change
4.22%
1-Year Change
698.10%
3-Year Change
818.003%
5-Year Change
531.27%
All-Time (Max) Change
633.31%

Contact Information

763 392 0767
16305–36th Avenue North, Minneapolis, MN, 55446

Company Facts

870 Employees
IPO DateSep 20, 2017
CountryUS
Actively Trading

Frequently Asked Questions